浙江震元(000705) - 2014 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥513,651,063.87, representing a year-on-year increase of 7.36%[7] - Net profit attributable to shareholders of the listed company was ¥5,291,741.58, a significant decrease of 70.11% compared to the same period last year[7] - Basic earnings per share decreased by 69.81% to ¥0.016[7] - The weighted average return on net assets was 0.44%, down by 1.11 percentage points from the previous year[7] - Non-operating income for the year-to-date period amounted to ¥1,945,828.09[8] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,811,448,477.21, an increase of 3.88% compared to the end of the previous year[7] - Net assets attributable to shareholders of the listed company amounted to ¥1,216,069,133.02, reflecting a growth of 4.06% year-on-year[7] - The company's receivables decreased by 39.27% to ¥31,518,258.13 from ¥51,899,715.08 year-over-year[14] - Other receivables increased significantly by 207.52% to ¥20,238,148.55 from ¥6,581,005.65 year-over-year[14] - Available-for-sale financial assets rose by 130.27% to ¥88,935,312.03 from ¥38,622,016.37 year-over-year[14] - The company's short-term borrowings decreased by 58% to ¥10,500,000.00 from ¥25,000,000.00 year-over-year[14] - The deferred income tax liabilities increased by 30.89% to ¥11,829,735.14 from ¥9,038,236.23 year-over-year[14] - The company's income tax expense increased by 56.67% to ¥11,317,492.47 from ¥7,223,814.79 year-over-year[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 36,149[9] - The largest shareholder, Shaoxing Tourism Group Co., Ltd., held 19.94% of the shares, totaling 66,627,786 shares[9] - The company did not experience any changes in its total share capital due to new share issuance or other reasons during the reporting period[7] Cash Flow - The net cash flow from operating activities increased by ¥84,772,515.20, resulting in a positive cash flow of ¥16,791,587.05 compared to a negative cash flow in the previous year[14] Capital Changes - The company's capital stock increased by 100% to ¥334,123,286.00 from ¥167,061,643.00 year-over-year due to capital reserve conversion[15] - The company sold fractional shares for a net income of ¥316.34, which was included in the capital reserve[16] Company Activities - The company conducted multiple on-site research meetings with various financial institutions in August 2014[21] - No specific financial data or performance metrics were provided in the reports[21] - The focus of the meetings was on the company's production and operational conditions for the first half of 2014[21] Investment Holdings - The company holds 79.6 million shares of East China Pharmaceutical (000963), accounting for 0.21% of its total equity[19]